121 related articles for article (PubMed ID: 37742818)
1. Therapeutic potential and protective role of GRK6 overexpression in pulmonary arterial hypertension.
Liu C; Wan N; Wei L; Rong W; Zhu W; Xie M; Zhang Y; Liu Z; Jing Q; Lyu A
Vascul Pharmacol; 2023 Dec; 153():107233. PubMed ID: 37742818
[TBL] [Abstract][Full Text] [Related]
2. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
[TBL] [Abstract][Full Text] [Related]
3. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
[TBL] [Abstract][Full Text] [Related]
4. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
[TBL] [Abstract][Full Text] [Related]
5. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
6. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator Inhibitor-2 inhibits pulmonary arterial smooth muscle cell proliferation in pulmonary arterial hypertension via PI3K/Akt and ERK signaling.
Zhang S; Wang J; Qi X; Tao X; Xie W; Wan J; Shen YH; Zhai Z
Exp Cell Res; 2021 Jan; 398(1):112392. PubMed ID: 33227315
[TBL] [Abstract][Full Text] [Related]
8. FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension.
Yeo Y; Yi ES; Kim JM; Jo EK; Seo S; Kim RI; Kim KL; Sung JH; Park SG; Suh W
Hypertension; 2020 Dec; 76(6):1778-1786. PubMed ID: 33100045
[TBL] [Abstract][Full Text] [Related]
9. STARS knockout attenuates hypoxia-induced pulmonary arterial hypertension by suppressing pulmonary arterial smooth muscle cell proliferation.
Shi Z; Wu H; Luo J; Sun X
Biomed Pharmacother; 2017 Mar; 87():397-404. PubMed ID: 28068629
[TBL] [Abstract][Full Text] [Related]
10. The HIF-1α/miR-26a-5p/PFKFB3/ULK1/2 axis regulates vascular remodeling in hypoxia-induced pulmonary hypertension by modulation of autophagy.
Ma C; Xu Q; Huang S; Song J; Sun M; Zhang J; Chu G; Zhang B; Bai Y; Zhao X; Wang Z; Li P
FASEB J; 2023 May; 37(5):e22906. PubMed ID: 37052859
[TBL] [Abstract][Full Text] [Related]
11. GRK2-YAP signaling is implicated in pulmonary arterial hypertension development.
Ye P; Deng Y; Gu Y; Liu P; Luo J; Pu J; Chen J; Huang Y; Wang N; Ji Y; Chen S
Chin Med J (Engl); 2024 Apr; 137(7):846-858. PubMed ID: 38242702
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of DYRK1A attenuates vascular remodeling in pulmonary arterial hypertension via suppressing STAT3/Pim-1/NFAT pathway.
Lan C; Fang G; Qiu C; Li X; Yang F; Yang Y
Clin Exp Hypertens; 2024 Dec; 46(1):2297642. PubMed ID: 38147409
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal.
Yang Y; Yin L; Zhu M; Song S; Sun C; Han X; Xu Y; Zhao Y; Qi Y; Xu L; Peng JY
Biomed Pharmacother; 2021 Jan; 133():111056. PubMed ID: 33378960
[TBL] [Abstract][Full Text] [Related]
15. Nur77 suppresses pulmonary artery smooth muscle cell proliferation through inhibition of the STAT3/Pim-1/NFAT pathway.
Liu Y; Zhang J; Yi B; Chen M; Qi J; Yin Y; Lu X; Jasmin JF; Sun J
Am J Respir Cell Mol Biol; 2014 Feb; 50(2):379-88. PubMed ID: 24047441
[TBL] [Abstract][Full Text] [Related]
16. The novel roles of YULINK in the migration, proliferation and glycolysis of pulmonary arterial smooth muscle cells: implications for pulmonary arterial hypertension.
Wu YC; Wang WT; Yang MC; Su YT; Yeh JL; Hsu JH; Wu JR
Biol Res; 2023 Dec; 56(1):66. PubMed ID: 38057829
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV attenuates hypoxia‑induced pulmonary vascular remodeling via the Notch signaling pathway.
Yao J; Fang X; Zhang C; Yang Y; Wang D; Chen Q; Zhong G
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236156
[TBL] [Abstract][Full Text] [Related]
18. Stox1 induced the proliferation and cell cycle arrest in pulmonary artery smooth muscle cells via AKT signaling pathway.
Xu Y; Sun Z; Wang Q; Wang T; Liu Y; Yu F
Vascul Pharmacol; 2019 Sep; 120():106568. PubMed ID: 31207359
[TBL] [Abstract][Full Text] [Related]
19. Platelet-Derived TGF (Transforming Growth Factor)-β1 Enhances the Aerobic Glycolysis of Pulmonary Arterial Smooth Muscle Cells by PKM2 (Pyruvate Kinase Muscle Isoform 2) Upregulation.
Zhu Y; Shu D; Gong X; Lu M; Feng Q; Zeng XB; Zhang H; Gao J; Guo YW; Liu L; Ma R; Zhu L; Hu Q; Ming ZY
Hypertension; 2022 May; 79(5):932-945. PubMed ID: 35232222
[TBL] [Abstract][Full Text] [Related]
20. CPT1 regulates the proliferation of pulmonary artery smooth muscle cells through the AMPK-p53-p21 pathway in pulmonary arterial hypertension.
Zhuang W; Lian G; Huang B; Du A; Gong J; Xiao G; Xu C; Wang H; Xie L
Mol Cell Biochem; 2019 May; 455(1-2):169-183. PubMed ID: 30511343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
